The DNA Replication Program Is Altered at the FMR1 Locus in Fragile X Embryonic Stem Cells

被引:81
作者
Gerhardt, Jeannine [1 ]
Tomishima, Mark J. [2 ]
Zaninovic, Nikica [3 ]
Colak, Dilek [4 ]
Yan, Zi [1 ]
Zhan, Qiansheng [3 ]
Rosenwaks, Zev [3 ]
Jaffrey, Samie R. [4 ]
Schildkraut, Carl L. [1 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA
[2] Sloan Kettering Inst, SKI Stem Cell Res Facil, New York, NY 10065 USA
[3] Weill Cornell Med Coll, Ctr Reprod Med & Infertil, New York, NY 10065 USA
[4] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA
关键词
HEREDITARY-DISEASE GENES; BARR-VIRUS EPISOMES; SYNTHESIS IN-VITRO; REPEAT INSTABILITY; TRINUCLEOTIDE REPEAT; CGG REPEAT; FULL MUTATION; DYNAMIC MUTATIONS; TRIPLET REPEATS; PRIMATE CELLS;
D O I
10.1016/j.molcel.2013.10.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fragile X syndrome (FXS) is caused by a CGG repeat expansion in the FMR1 gene that appears to occur during oogenesis and during early embryogenesis. One model proposes that repeat instability depends on the replication fork direction through the repeats such that (CNG)(n) hairpin-like structures form, causing DNA polymerase to stall and slip. Examining DNA replication fork progression on single DNA molecules at the endogenous FMR1 locus revealed that replication forks stall at CGG repeats in human cells. Furthermore, replication profiles of FXS human embryonic stem cells (hESCs) compared to nonaffected hESCs showed that fork direction through the repeats is altered at the FMR1 locus in FXS hESCs, such that predominantly the CCG strand serves as the lagging-strand template. This is due to the absence of replication initiation that would typically occur upstream of FMR1, suggesting that altered replication origin usage combined with fork stalling promotes repeat instability during early embryonic development.
引用
收藏
页码:19 / 31
页数:13
相关论文
共 58 条
[1]   Repeat instability as the basis for human diseases and as a potential target for therapy [J].
Castel, Arturo Lopez ;
Cleary, John D. ;
Pearson, Christopher E. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (03) :165-170
[2]   A late origin of DNA replication in the trinucleotide repeat region of the human FMR2 gene [J].
Chastain, Paul D., II ;
Cohen, Stephanie M. ;
Brylawski, Bruna P. ;
Cordeiro-Stone, Marila ;
Kaufman, David G. .
CELL CYCLE, 2006, 5 (08) :869-872
[3]   Replication fork dynamics and dynamic mutations: the fork-shift model of repeat instability [J].
Cleary, JD ;
Pearson, CE .
TRENDS IN GENETICS, 2005, 21 (05) :272-280
[4]   Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells [J].
Cleary, JD ;
Nichol, K ;
Wang, YH ;
Pearson, CE .
NATURE GENETICS, 2002, 31 (01) :37-46
[5]   Tissue- and age-specific DNA replication patterns at the CTG/CAG-expanded human myotonic dystrophy type 1 locus [J].
Cleary, John D. ;
Tome, Stephanie ;
Castel, Arturo Lopez ;
Panigrahi, Gagan B. ;
Foiry, Laurent ;
Hagerman, Katharine A. ;
Sroka, Hana ;
Chitayat, David ;
Gourdon, Genevieve ;
Pearson, Christopher E. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (09) :1079-U7
[6]   Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders [J].
De Rubeis, Silvia ;
Bagni, Claudia .
JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2011, 3 (03) :257-269
[7]   Single-stranded DNA-binding protein in vitro eliminates the orientation-dependent impediment to polymerase passage on CAG/CTG repeats [J].
Delagoutte, Emmanuelle ;
Goellner, Geoffrey M. ;
Guo, Jie ;
Baldacci, Giuseppe ;
McMurray, Cynthia T. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (19) :13341-13356
[8]   ANALYSIS OF FULL FRAGILE-X MUTATIONS IN FETAL TISSUES AND MONOZYGOTIC TWINS INDICATE THAT ABNORMAL METHYLATION AND SOMATIC HETEROGENEITY ARE ESTABLISHED EARLY IN DEVELOPMENT [J].
DEVYS, D ;
BIANCALANA, V ;
ROUSSEAU, F ;
BOUE, J ;
MANDEL, JL ;
OBERLE, I .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 43 (1-2) :208-216
[9]  
Dobkin CS, 1996, AM J MED GENET, V64, P296, DOI 10.1002/(SICI)1096-8628(19960809)64:2<296::AID-AJMG13>3.3.CO
[10]  
2-W